Skip to main content
. Author manuscript; available in PMC: 2023 Apr 18.
Published in final edited form as: Psychiatr Genet. 2020 Oct;30(5):125–135. doi: 10.1097/YPG.0000000000000258

Table 3.

Effect of tardive dyskinesia status, smoking status, the two SNPs and their interaction on Aligned Rank Transform of Abnormal Involuntary Movement Scale tardive dyskinesia score

Effect F P value Power (%)
Tardive dyskinesia status F(1,148) = 75.39 6.5 × 10−15# 100.0
Smoking F(2,148) = 16.34 3.9 × 10−7# 100.0
rs1076560 F(2,148) = 2.33 0.10 46.6
rs4680 F(2,148) = 3.27 0.04# 61.4
Tardive dyskinesia status*Smoking F(2,148) = 5.36 0.01# 83.5
Tardive dyskinesia status* rs1076560 F(2,148) = 0.07 0.93 6.1
Smoking* rs1076560 F(3,148) = 3.57 0.02# 78.0
Tardive dyskinesia status* rs4680 F(2,148) = 1.46 0.24 30.8
Smoking* rs4680 F(4,148) = 5.35 4.7 × 10−4# 97.0
rs1076560*rs4680 F(4,148) = 7.53 1.5 × 10−5# 99.6
Tardive dyskinesia status*Smoking* rs4680 F(2,148) = 0.38 0.68 11.0
Tardive dyskinesia status*Smoking* rs1076560 F(1,148) = 0.59 0.44 11.9
Tardive dyskinesia status* rs1076560*rs4680 F(3,148) = 2.72 0.05# 65.1
Smoking* rs1076560*rs4680 F(2,148) = 15.29 9.2 × 10−7# 99.9
Tardive dyskinesia status*Smoking* rs1076560*rs4680 F(1,139) = 0.60 0.44 12.0

The main effects of tardive dyskinesia status, Smoking and rs4680 were found to significantly affect AIMSart tardive dyskinesia score. The interactions of tardive dyskinesia status*Smoking, Smoking*rs1076560, Smoking*rs4680, tardive dyskinesia status* rs1076560*rs4680 and smoking* rs1076560*rs4680 withstood Bonferroni multiple comparisons post-ANOVA.

ANOVA, analysis of variance; SNP, single nucleotide polymorphism.

#P value < 0.05.